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the T cell system in itself and its very high sensitivity to A major function for CD40 on B cells is to transmit signals
from CD40L (CD154) helper T cells to follicular (FO) Bpeptide-MHC complexes. Since the T cells can respond
cells. These responses to T cell-dependent (TD) anti-in vivo to a handful of peptide-MHC complexes per APC
gens (Ags) lead to germinal center (GC) formation fol-(for example, DiPaolo and Unanue, 2002), many intracel-
lowed by memory B cell formation (Clark and Ledbetter,lular routes, regardless of their efficiency, and many
1994; Grewal and Flavell, 1998). End of story? Not quite.peptides, regardless of their affinity for MHC molecules,
A number of puzzles remain, including the function ofcan produce enough T cell receptor ligands to trigger
CD40 on memory B cells and splenic marginal zone (MZ)a response.
B cells. MZ B cells contain both IgM memory B cellsThese points are all relevant to a critical issue, namely
and B cells designed to respond rapidly to T cell-inde-the extent to which the antigens presented by cells in-
pendent type 2 (TI-2) polysaccharide Ags. Interestingly,fected with wild-type versus avirulent dotA mutants
they proliferate much better in response to CD40 ligationoverlap. Does the fusion with lysosomes in the latter
and are better Ag-presenting cells than FO B cells (Olivercase change the set of peptides presented by the class
et al., 1997). In contrast, FO B cells respond better toII molecules and what does this mean for vaccine ap-
TI-1-like stimuli. Memory B cells respond to and mayproaches? Likewise, does the difference in vesicular
be recruited to the MZ by polysaccharides and otherenvironment alter gene expression and hence, antigenic
bacterial products such as CpG DNA (Vinuesa et al.,profile? The implications of there being microbial anti-
2003; Bernasconi et al., 2002). Overall, the roles CD40-gens that are expressed and/or processed only under
expressing B cells play during inflammatory responsessome circumstances are of considerable importance.
and in the MZ are not well understood.The system described by Neild and Roy comparing DC
Clearly CD40 on B cells can do more than simply driveand macrophages and the wild-type and dotA mutants
FO B cells to become memory B cells. Yasui et al. (2002)of Legionella is ideal to examine the intracellular steps
in an elegant study have shown that the cytoplasmicin presentation of microbial antigens, as well as their
tail of CD40 has two distinct functional domains—onebiological relevance.
for induction of extrafollicular B cells in periarteriolar
lymphoid sheaths (PALS) and the start of GC formation,
Emil R. Unanue and another for GC formation. So like other TNF receptor
Department of Pathology and Immunology family members, CD40 has the wiring to mediate several
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St. Louis, Missouri 63110 The findings of Brodeur et al. suggest that the CD40
pathway may be influenced by changes during innate
immune responses. They report that the disulfide-linkedSelected Reading
heptamer, C4BP, which is regulated by inflammatory
cytokines, could bind to CD40 on B cells and activateArmstrong, J., and Hart, P.D. (1971). J. Exp. Med. 134, 713–740.
them. C4BP did not bind to B cells from a CD40-deficientBhardwaj, N., Nash, T.W., and Horwitz, M.A., (1986). J. Immunol.
hyper IgM (HIGM) syndrome patient or activate B cells137, 2662–2669.
missing a key component of the CD40 signaling path-DiPaolo, R.J., and Unanue, E.R. (2002). J. Immunol. 169, 1–4.
way, IKK/NEMO. In the presence of IL-4, C4BP likeGarin, J., Diez, R., Kieffer, S., Dermine, J.F., Duclos, S., Gagnon, E.,
CD154 caused isotype switching to IgE. And B cell-Sadoul, R., Rondeau, C., and Desjardins, M. (2001). J. Cell Biol. 152,
165–180. derived CD40L was not required for C4BP to induce
proliferation or isotype switching. Thus, based on a num-Horwitz, M.A. (1983). J. Exp. Med. 158, 1319–1331.
ber of criteria, C4BP directly activates the CD40 pathwayKagan, J.C., and Roy, C.R. (2002). Nat. Cell Biol. 4, 945–954.
in B cells.Neild, A.L., and Roy, C.R. (2003). Immunity 18, this issue, 813–823.
A major function of C4BP is to bind to and promoteRamachandra, L., Noss, E., Boom, W.H., and Harding, C.V. (1999).
the decay and degradation of C4b, a component of theCellular Microbiology 1, 205–214.
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or 7  chains attached together at a base like a “fan,”Sturgill-Koszycki, S., and Swanson, M.S. (2000). J. Exp. Med. 192,
with or without a short  chain. Like other complement1261–1272.
binding proteins such as CR1/CD35 and CR2/CD21, the
C4BP heptamer (71) is made up of a string of short
consensus repeats (SCRs) or complement control pro-
tein (CCP) modules. Each SCR (8 in each  chain and
A CD40 Bridge between 3 in the  chain) has 60 amino acid residues and 4
highly conserved cysteines, which form intrachain disul-Innate and Adaptive Immunity
fide bridges. C4BP binds to CD40 via its  chains, so
one can envision “open fan” C4BP heptamers potentially
being even more efficient than CD154 trimers in activat-
In this issue of Immunity, Brodeur et al. show that C4b ing B cells.
binding protein (C4BP), a regulator component of the Binding of C4BP did not block the binding of CD40L
classical complement (C) pathway, can bind to CD40 to B cells and vice versa. This suggests that CD154 and
receptors on B cells and activate them. This suggests C4BP bind to distinct sites on CD40, and therefore,
a novel way by which CD40 may function to bridge theoretically could act together to affect B cell matura-
tion. Further studies are required to determine the rela-innate and adaptive immune responses.
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tive binding affinities of CD154 versus C4BP and filarial parasitic antigen (Imai et al., 2001). Thus, C4BP
and CD40 may bridge innate and adaptive immune re-whether the binding of one ligand can modify the affinity
of binding of the other. If C4BP stimulates CD40 inde- sponses to bacteria as well as other pathogens.
Among the important unanswered questions ispendently of CD40L, then one would expect CD40-
versus CD154 (CD40L)-deficient mice or humans to dif- whether C4BP can activate CD40 cells like dendritic
cells, endothelial cells, epithelial cells, or, as reportedfer in some clear way. The phenotypes observed in
CD40/ and CD154/ mice are very similar (see Grewal recently, CD8 memory T cells—each of which has a
characteristic response to CD40 signaling. It will alsoand Flavell, 1998) and the clinical picture of patients
with CD40 hyper IgM deficiency (HIGM3) is very similar be important to know which SCRs in C4BP binds to
CD40 versus bacterial products. For instance, the outerto patients with CD154 or HIGM1 deficiency (Ferrari et
al., 2001; Kutukculer et al., 2003). Unlike patients with membrane protein of E. coli binds to SCR3 of C4BP
(Prasadarao et al., 2002), so if CD40 binds to SCR1 ordefects in AID (HIGM2) or NEMO, patients with CD40 or
2, then it could function to bring bacterial products intoCD154 deficiencies frequently have neutropenia and are
closer proximity with TLR or other pattern recognitionmore susceptible to characteristic opportunistic infec-
receptors on B cells or DCs. It will also be useful totions. However, it may be worth looking more closely
compare the relative affinities of CD40 to its variousfor possible differences between CD40L- versus CD40-
binding partners: CD154, hsp70, and C4BP.deficient mice, e.g., in responses to pathogens inducing
both innate and adaptive immunity.
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